Karnali Academy of Health Sciences(KAHS)

Jumla,Karnali, Nepal

Dirgha Raj Joshi, PhD

Dirgha Raj Joshi, PhD
Faculty Members Of KAHS
dirgha@kahs.edu.np
087520355
KAHS

 

Dirgha Raj Joshi, Ph.D.
Assistant Professor of Medicinal Chemistry
School of Pharmacy, Karnali Academy of Health Sciences
ID: 1064

 

Dr. Dirgha Raj Joshi holds a Bachelor of Pharmacy degree from Pokhara University, Nepal, followed by a Master's in Pharmacy (Medicinal Chemistry) from Wonkwang University, South Korea. Motivated by a deep curiosity for scientific inquiry, he pursued a Ph.D. in Organic/Medicinal Chemistry at Yonsei University, South Korea. He later completed his postdoctoral research at the National Institutes of Health (NIH) in the USA.

During his Ph.D., Dr. Joshi made significant contributions to heterocyclic chemistry, developing four novel synthetic methodologies and securing three patents. His postdoctoral research focused on antiviral drug discovery for SARS-CoV-2, specifically targeting the PLPro protein. He has authored over 30 peer-reviewed scientific publications and has served as a reviewer for various journals.

Currently, Dr. Joshi is an Assistant Professor at the School of Pharmacy, Karnali Academy of Health Sciences (KAHS), where he focuses on both teaching and research for undergraduate and graduate students.

Beyond his academic work, Dr. Joshi is passionate about raising public awareness on health and medicine. He is the author of the book “Ausadhi ko Gyan, Swostha Jyan” and has organized several public awareness programs. He has also held leadership roles in various organizations, including CAPS, SONSIK, PVP Nepal, and Gita4Life.

His few selected Publications:

  1. Joshi DR, Kim I. Regioselective Synthesis of 1‐Cyano‐3‐arylindolizines: Construction of Pyrroles via DDQ‐Mediated Ring Closure of Cyclopropyl Pyridines. Adv. Synth. & Catal. 2022.
  2. Joshi DR, Kim I; Synthesis of Poly-Functionalized Indolizines via [5+1] Annulative Access to Pyridines. Adv. Synth. & Catal. 2021.
  3. Joshi DR, Seo Y, Heo Y, Park S, Lee Y, Namkunh W, Kim I; Domino [4 + 2] Annulation Access to Quinone–Indolizine Hybrids: Anticancer N-Fused PolycyclesJ. Org. Chem. 2020.
  4. Joshi DR, Kim I; Michael-Aldol-Double Elimination Cascade to Make Pyridines: Use of Chromone for the Synthesis of Indolizines. J. Org. Chem. 2021. 

To learn more about Dr. Joshi, visit: